carnitine has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acylcarnitines were also affected, suggestive of a mitochondrial fatty acid oxidation disorder." | 1.56 | Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1). ( Houweling, PJ; Kaur, T; Little, DG; Roessner, U; Rupasinghe, T; Schindeler, A; Summers, MA; Vasiljevski, ER, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Vasiljevski, ER | 3 |
| Houweling, PJ | 1 |
| Rupasinghe, T | 2 |
| Kaur, T | 1 |
| Summers, MA | 3 |
| Roessner, U | 2 |
| Little, DG | 3 |
| Schindeler, A | 3 |
| Burns, J | 1 |
| Bray, P | 1 |
| Donlevy, G | 1 |
| Mudge, AJ | 1 |
| Jones, KJ | 1 |
| Biggin, A | 1 |
| Munns, CF | 1 |
| McKay, MJ | 1 |
| Baldwin, JN | 1 |
| Evesson, FJ | 1 |
| Mikulec, K | 1 |
| Peacock, L | 1 |
| Quinlan, KG | 1 |
| Cooper, ST | 1 |
| Stevenson, DA | 1 |
1 trial available for carnitine and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.
Topics: Cardiomyopathies; Carnitine; Child; Dietary Supplements; Fatigue; Female; Humans; Hyperammonemia; Ma | 2021 |
2 other studies available for carnitine and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
Topics: Animals; Carnitine; Dietary Supplements; Fatty Acids; Female; Lipid Metabolism; Mice; Muscle Strengt | 2020 |
Dietary intervention rescues myopathy associated with neurofibromatosis type 1.
Topics: Adolescent; Adult; Animals; Carnitine; Child; Child, Preschool; Fatty Acids; Female; Humans; Lipid M | 2018 |